Create a free research account to view current pricing and place an order.
Mechanism of action
5-Amino-1MQ is researched primarily as an NNMT inhibitor. NNMT inhibition may influence NAD+ metabolism, methylation balance, adipocyte metabolic efficiency, and cellular energy-utilization pathways relevant to metabolic regulation.
Half-life & pharmacokinetics
Half-life: Short systemic exposure; injectable PK not standardized.
Human injectable PK is not standardized. Treat as short systemic exposure with daily research cadence when injectable preparation is used; avoid oral-equivalent dose assumptions.
Research dosing reference
2.5-5 mg daily as injectable research reference; avoid oral-equivalent dose assumptions.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 2.5 mg | 100 units |
| 5 mg | 200 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 5 mg | 2 mL BAC Water | 0.025 mg/unit |
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
| 50 mg | 2 mL BAC Water | 0.250 mg/unit |
Injection timing
Daily administration; morning or pre-activity timing is often preferred for metabolic interpretation.
Beginner escalation
Begin at 2.5 mg daily and evaluate GI, appetite, energy, and injection tolerance before moving upward.
Side-effect mitigation
Monitor GI upset, appetite shifts, fatigue, injection-site tolerance, and hydration status.
Stack compatibility
Often paired conceptually with GLP/metabolic protocols, AOD-9604, or mitochondrial agents. Avoid assuming oral and injectable dosing are interchangeable.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Commonly structured as 4-12 week metabolic blocks followed by reassessment of energy, appetite, body-composition trend, GI tolerance, and objective need before extension or repeat course.
Frequently asked questions
What is 5 Amino 1MQ and how does it work?
5-Amino-1MQ is researched primarily as an NNMT inhibitor. NNMT inhibition may influence NAD+ metabolism, methylation balance, adipocyte metabolic efficiency, and cellular energy-utilization pathways relevant to metabolic regulation.
What is the half-life of 5 Amino 1MQ?
5 Amino 1MQ: Short systemic exposure; injectable PK not standardized. Human injectable PK is not standardized. Treat as short systemic exposure with daily research cadence when injectable preparation is used; avoid oral-equivalent dose assumptions.
How is 5 Amino 1MQ reconstituted for research?
Preferred reconstitution for the 5 mg vial is 2 mL BAC Water, giving 0.025 mg/unit. Always confirm concentration math before any use. Research use only.
Is 5 Amino 1MQ FDA approved?
No. 5 Amino 1MQ is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration